Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

TissueGene changes name to Kolon TissueGene

March 19, 2018

Patient enrollment ongoing in phase II study of BCD-089

March 16, 2018

Medshine Discovery patents new PDE4 inhibitors

March 15, 2018

Kezar Life Sciences initiates phase I/II study of KZR-616 in SLE

March 12, 2018

FDA grants regenerative medicine advanced therapy designation to AmnioFix

March 12, 2018

First-in-human results for Progenza in patients with knee osteoarthritis

March 12, 2018

FDA grants allowance of IND for FCX-013 gene therapy for scleroderma

March 7, 2018

EMA committee hands down positive opinion for Kineret in Still's disease

Feb. 26, 2018

Orencia approved for active polyarticular JIA in Japan

Feb. 26, 2018

Phase II development of LY-3337641 for rheumatoid arthritis ended

Feb. 20, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...